This expert review describes screening, brief intervention, and referral to treatment (SBIRT) as an approach to identifying and responding to substance use during pregnancy. Drawing on a multidisciplinary expert meeting convened by the US Centers for Disease Control and Prevention, the authors discuss routine, validated screening, nonjudgmental brief conversations, and referral for specialized treatment when needed. They emphasize that substance use is often overlooked in prenatal care despite potential consequences for pregnant patients and infants. The article synthesizes evidence and clinical recommendations rather than reporting a new randomized trial.
